Regulation of cell growth and the expression of extracellular matrix proteins in colorectal adenocarcinoma: A fibroblast-tumor cell coculture model to study tumor-host interactions in vitro

European Journal of Cell Biology

Volumn 82, Issue 1, 2003, Pages 1-8

  Hauptmann, Steffen ^a   Siegert, Antje ^a   Berger, Stefan ^a   Denkert, Carsten ^a   Köbel, Martin ^a   Ott, Stefan ^a   Siri, Annalisa ^b   Borsi, Laura ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Colon carcinoma; Extracellular matrix proteins; Tenascin C; Tumor stroma

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADENOCARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; COCULTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FETUS; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOLAYER CULTURE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

EID: 0037261751     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-9335-00283     Document Type: Review

References (32)

1. Bissel, M. J., Radisky, D. (2001): Putting tumours in context. Nature Rev. Cancer 1, 46-54.
2. Borsi, L., Carnemolla, B., Nicolo, G., Spina, B., Tanara, G., Zardi, L. (1992): Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer 52, 688-692.
3. Carnemolla, B., Balza, E., Siri, A., Zardi, L., Nicotra, M. R., Bigotti, A., Natali, P. G. (1989): A tumor-associated fibronectin isoform generated by alternatively splicing of messenger RNA precursors. J. Cell Biol. 108, 1139-1148.
4. Chantret, I., Barbat, A., Dussaulx, E., Brattain, M. G., Zweibaum, A. (1988): Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res. 48, 1936-1942.
5. Dvorak, H. F. (1985): Tumors: wounds that do not heal. New Engl. J. Med. 26,1650-1659.
6. Emura, M., Ochiai, A., Horino, M., Arndt, W., Kamino, K., Hirohashi, S. (2000): Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cell Dev. Biol. Anim. 36, 77-80.
7. Gabbiani, G. (1996): The cellular derivation and the life span of the myofibroblast. Pathol. Res. Pract. 192, 708-711.
8. Grégoire, M., Lieubeau, B. (1995): The role of fibroblasts in tumor behaviour. Cancer Metastasis Rev. 14, 339-350.
9. Halvorsen, T. B., Seim, E. (1989): Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J. Clin. Pathol. 42, 162-166.
10. Hanamura, N., Yoshida, T., Matsumoto, E., Kawarada, Y., Sakakura, T. (1997): Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas. Int. J. Cancer 73, 10-15.
11. Hauptmann, S., Zardi, L., Siri, A., Carnemolla, B., Borsi, L., Castelluci, M., Klosterhalfen, B., Hartung, P., Weis, J., Stöcker, G., Haubeck, H. D., Kirkpatrick, C. J. (1995): Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab. Invest. 73, 172-182.
12. Ibrahim, S. N., Lightner, V. A., Ventimiglia, J. B., Ibrahim, G. K., Walther, P. J., Bigner, D. D. (1993): Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. Hum. Pathol. 24, 982-989.
13. Ignotz, R., Massague, J. (1986): Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261, 4337-4345.
14. Kressner, U., Lindmark, G., Tomasini-Johanssson, B., Bergstrom, R., Gerdin, B., Pahlman, L., Glimelius, B. (1997): Stromal tenascin distribution as prognostic marker in colorectal cancer. Br. J. Cancer 76, 526-530.
15. Linnala, A., Kinnula, V., Laitinen, L. A., Lehto, V. D., Virtanen, I. (1995): Transforming growth factor β regulates the expression of fibronectin and tenascin in BEAS 2B human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 13, 578-585.
16. Liotta, L. A., Kohn, E. C. (2001): The microenvironment of the tumour-host interface. Nature 411, 375-379.
17. Lorena, D., Uchio, K., Monte Alto Costa, A., Desmoulière, A. (2002): Normal scarring: importance of myofibroblasts. Wound Repair Regen. 10, 86-92.
18. Martin, M., Pujuguet, P., Martin, F. (1996): Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol. Res. Pract. 192, 712-717.
19. Meiners, L., Marone, M., Rittenhouse, J. C., Geller, H. M. (1993): Regulation of astrocytic tenascin by fibroblast growth factor. Dev. Biol. 160, 480-493.
20. Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K., Schiguchi, K. (1991): Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissue: comparison with fibronectin. Cancer Res. 47, 811-816.
21. Park, C.C., Bissell, M. J., Barcellos-Hoff, M. H. (2000): The influence of the microenvironment on the malignant phenotype. Mol. Med. Today 6, 324-329.
22. Pearson, C., Pearson, D., Shibahara, S., Hofsteenge, J., Chiquet-Ehrismann, R. (1988): Tenascin: cDNA cloning and induction by TGFβ. EMBO J. 7, 2977-2982.
23. Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., West, A. B. (1999a): Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C19.
24. Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., West, A. B. (1999b): Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am. J. Physiol. 277, C183-C201.
25. Robson, H., Anderson, E., James, R. D., Schofield, P. F. (1996): Transforming growth factor β1 expression in human colorectal tumors: an independent prognostic marker in a subgroup of poor prognosis patients. Br. J. Cancer 74, 753-758.
26. Schollmann, C., Grugel, R., Tatje, D., Hoppe, J., Folkman, J., Marmé, D., Weich, H. A. (1992): Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of PDGFalpha receptor in vascular smooth muscle cells. J. Biol. Chem. 267, 18032-18039.
27. Siri, A., Carnemolla, B., Saginati, M., Leprini, A., Casari, G., Baralle, F., Zardi, L. (1991): Human tenascin: primary structure, pre m-RNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Nucleic Acids Res. 19, 525-531.
28. Tompkins, W. A. F., Watrach, A. M., Schmale, J. D., Schultz, R. M., Harris, J. A. (1974): Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J. Natl. Cancer Inst. 52, 1101-1110.
29. Tsushima, H., Ito, N., Tamura, S., Matsuda, Y., Inada, M., Yabuuchi, I., Imai, Y., Nagashima, R., Misawa, H., Takeda, H., Matsuzawa, Y., Kawata, S. (2001): Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection on colorectal cancer. Clin. Cancer Res. 7, 1258-1262.
30. Tucker, R. P., Hammerback, J. A., Jenrath, D. A., Mackie, E. J., Xu, Y. (1993): Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J. Cell Sci. 104, 69-77.
31. van Roozendaal, K. E. P., Klijn, J. G. M., Van Ooijen, B., Claassen, C., Eggermont, A. M. M., Henzen-Logmans, S. C., Foekens, J. A. (1996): Different regulations of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources. Int. J. Cancer 65, 120-125.
32. Varga, J., Rosenbloom, J., Jimenez, S. A. (1987): Transforming growth factor β (TGF-β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem. J. 247,